IDA 12 Months Study - Polyacrylamide hydrogel injection for knee osteoarthritis: results of a 52-week prospective study. Poster 336 was presented at OARSI Connect 2021.
The primary objective of the IDA 12 months study was to evaluate the efficacy and safety of a single injection of 6ml intra-articular (IA) injection of polyacrylamide hydrogel (PAAG) on knee symptoms in participants with moderate to severe knee osteoarthritis (OA).
An abstract poster (336) with the results from the IDA 12 Months study was presented by Prof. Henning Bliddal at the Osteoarthritis Research Society International OARSI Connect 2021.
To learn more about the IDA 12 Months study, please click the link above.